h i g h l i g h t s
Increased sampling rates did not improve seizure onset human marking under clinical conditions. Interrater and intrarater reliability of visually evaluated intracranial EEG is poor. Automated detection algorithms are needed to utilize higher EEG sampling rates in clinical practice.
a b s t r a c t
Objective: Recent research suggests that high frequency intracranial EEG (iEEG) may improve localization of epileptic networks. This study aims to determine whether recording macroelectrode iEEG with higher sampling rates improves seizure localization in clinical practice. Methods: 14 iEEG seizures from 10 patients recorded with >2000 Hz sampling rate were downsampled to four sampling rates: 100, 200, 500, 1000 Hz. In the 56 seizures, seizure onset time and location was marked by 5 independent, blinded EEG experts. Results: When reading iEEG under clinical conditions, there was no consistent difference in time or localization of seizure onset or number of electrodes involved in the seizure onset zone with sampling rates varying from 100 to 1000 Hz. Stratification of patients by outcome did not improve with higher sampling rate. Conclusion: When utilizing standard clinical protocols, there was no benefit to acquiring iEEGs with sampling rate >100 Hz. Significant variability was noted in EEG marking both within and between individual expert EEG readers. Significance: Although commercial equipment is capable of sampling much faster than 100 Hz, tools allowing visualization of subtle high frequency activity such as HFOs will be required to improve patient care. Quantitative methods may decrease reader variability, and potentially improve patient outcomes. Ó 2017 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Introduction
For the $1/3 of epilepsy patients who are not controlled by medications alone, epilepsy surgery or the possibility of implantable devices to treat their seizures may be the only therapeutic option. However, the success rates of epilepsy surgery vary broadly from 40 to 80% (Cohen-Gadol et al., 2006; Lee et al., 2005; Mohammed et al., 2012; de Tisi et al., 2011) , and these numbers have not changed in many years. It is clear that the standard practice of evaluating epilepsy surgical candidates needs improvement. For this reason, the epilepsy community has great interest in identifying additional biomarkers to localize and characterize epileptic networks. 
